HoLEP for acute and non-neurogenic chronic urinary retention: how effective is it?
Tevita AhoWilliam FinchPhilippa JeffersonLokesh SuraparajuFanourios GeorgiadesPublished in: World journal of urology (2021)
HoLEP has 3-month catheter-free rates in excess of 98.5% for AUR and NNCUR in patients not pre-selected by UDS. First TWOC is significantly more likely to fail after HoLEP for NNCUR than AUR or LUTS. HoLEP is a durable treatment for HPCUR and there is no need to monitor renal function to detect recurrence.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- spinal cord injury
- prognostic factors
- respiratory failure
- drug induced
- patient reported outcomes
- lower urinary tract symptoms
- free survival
- smoking cessation
- extracorporeal membrane oxygenation
- replacement therapy
- mechanical ventilation